Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSabre Insur Regulatory News (SBRE)

Share Price Information for Sabre Insur (SBRE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 159.60
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 1.60 (1.005%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 159.60
SBRE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Post-Stabilisation Period Announcement

13 Dec 2017 17:50

RNS Number : 2927Z
Barclays Capital Securities Limited
13 December 2017
 

13 December 2017

Not for release, publication or distribution, in whole or in part, directly or indirectly, in or into the United States of America, Australia, Canada, Japan or South Africa or any jurisdiction in which such distribution would be unlawful.

Sabre Insurance Group plc

Pre-Stabilisation Period Announcement

Further to the pre-stabilisation period announcement dated 06 December 2017 Barclays Bank PLC ('Barclays') (Ben West; telephone: +44 20 7773 9531) hereby gives notice that as Stabilising Coordinator, the Stabilisation Manager named below undertook stabilisation (within the meaning of Article 3.2(d) of the Market Abuse Regulation (EU/596/2014) and of the rules of the Financial Conduct Authority) in relation to the offer of the following securities, as set out below.

 

The securities:

Issuer:

Sabre Insurance Group plc

Aggregate nominal amount/Offering size:

125,000,000 Ordinary Shares (excluding the over-allotment option)

Description:

Ordinary Shares in Sabre Insurance Group plc with a nominal value of £0.001. ISIN: GB00BYWVDP49

Offer price:

230p

Stabilisation:

Stabilisation Manager:

Barclays Capital Securities Limited, 5 The North Colonnade, Canary Wharf, London, E14 4BB, United Kingdom

Stabilisation started on:

6th December 2017

Stabilisation last occurred on:

13th December 2017

Stabilisation transactions:

Although stabilisation bids were made, no stabilisation transactions were carried out

In connection with the offer of the above securities, the Stabilisation Manager may over-allot the securities or effect transactions with a view to supporting the market price of the securities at a level higher than that which might otherwise prevail. However, stabilisation may not necessarily occur and any stabilisation action, if begun, may cease at any time. Any stabilisation action or overallotment shall be conducted in accordance with all applicable laws and rules.

This announcement is for information purposes only and does not constitute an invitation or offer to underwrite, subscribe for or otherwise acquire or dispose of any securities of the Issuer in any jurisdiction.

This announcement is only addressed to and directed at persons outside the United Kingdom and persons in the United Kingdom who have professional experience in matters related to investments falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (the Order) or who are high net worth persons falling within Article 49 of the Order and must not be acted on or relied on by other persons in the United Kingdom.

In addition, if and to the extent that this announcement is communicated in any EEA Member State that has implemented Directive 2003/71/EC (together with any applicable implementing measures in any Member State, the "Prospectus Directive") before the publication of a prospectus in relation to the securities to which this announcement relates which has been approved by the competent authority in that Member State in accordance with the Prospectus Directive (or which has been approved by a competent authority in another Member State and notified to the competent authority in that Member State in accordance with the Prospectus Directive), this announcement is only addressed to and directed at persons in that Member State who are qualified investors within the meaning of the Prospectus Directive (or who are other persons to whom the offer may lawfully be addressed) and must not be acted on or relied on by other persons in that Member State.

This announcement does not constitute, or form part of, an offer to sell, or a solicitation of an offer to purchase any securities in the United States or any other jurisdiction. The securities referred to herein have not been and will not be registered under the U.S. Securities Act of 1933, as amended (the "Securities Act"), and may not be offered or sold in the United States except to "qualified institutional buyers" as defined in, and in reliance on, Rule 144A under the Securities Act or another exemption from, or transaction not subject to, the registration requirements of the Securities Act. All offers and sales of securities outside of the United States will be made in reliance on, and in compliance with, Regulation S under the Securities Act. There is no intention to register any securities referred to herein in the United States or to make a public offering of the securities in the United States.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
STAGGGBCPUPMGMW
Date   Source Headline
12th Jan 202110:53 amRNSDirector/PDMR Shareholding
8th Jan 20219:44 amRNSHolding(s) in Company
11th Dec 20201:31 pmRNSDirector/PDMR Shareholding
3rd Dec 20207:56 amRNSHolding(s) in Company
3rd Dec 20207:00 amRNSBoard Appointment
27th Nov 20204:42 pmRNSSecond Price Monitoring Extn
27th Nov 20204:37 pmRNSPrice Monitoring Extension
11th Nov 202012:07 pmRNSDirector/PDMR Shareholding
6th Nov 202011:39 amRNSHolding(s) in Company
6th Nov 202010:55 amRNSHolding(s) in Company
27th Oct 20203:47 pmRNSDirector/PDMR Shareholding
15th Oct 20207:00 amRNSDirector/PDMR Shareholding
13th Oct 20209:42 amRNSDirector/PDMR Shareholding
13th Oct 20207:00 amRNSTrading Statement
11th Sep 202010:07 amRNSDirector/PDMR Shareholding
3rd Sep 20204:13 pmRNSDirector/PDMR Shareholding
1st Sep 20202:23 pmRNSDirector/PDMR Shareholding
28th Aug 202012:02 pmRNSPrice Monitoring Extension
27th Aug 202011:32 amRNSDirector/PDMR Shareholding
19th Aug 20207:00 amRNSDirectorate Change
12th Aug 20203:50 pmRNSHolding(s) in Company
11th Aug 20201:15 pmRNSDirector/PDMR Shareholding
10th Aug 20204:00 pmRNSHolding(s) in Company
6th Aug 202012:14 pmRNSDirector/PDMR Shareholding - Correction
6th Aug 202010:11 amRNSDirector/PDMR Shareholding
6th Aug 20209:32 amRNSDirector/PDMR Shareholding
3rd Aug 202012:54 pmRNSDirector/PDMR Shareholding
28th Jul 20207:02 amRNSBoard appointment
28th Jul 20207:00 amRNSHalf-year Report
14th Jul 20204:13 pmRNSHolding(s) in Company
13th Jul 202012:51 pmRNSDirector/PDMR Shareholding
30th Jun 20201:33 pmRNSDirector/PDMR Shareholding
11th Jun 20201:59 pmRNSDirector/PDMR Shareholding
10th Jun 20209:57 amRNSDirector/PDMR Shareholding - Correction
4th Jun 20209:49 amRNSDirector/PDMR Shareholding
29th May 20203:39 pmRNSDirector/PDMR Shareholding
29th May 202012:37 pmRNSDirector/PDMR Shareholding
21st May 202012:17 pmRNSResult of AGM
21st May 20207:00 amRNSTrading Statement
13th May 20202:24 pmRNSDirector/PDMR Shareholding
12th May 202011:54 amRNSDirector/PDMR Shareholding
12th May 20207:00 amRNSHolding(s) in Company
1st May 202011:58 amRNSHolding(s) in Company
27th Apr 20207:00 amRNSNotice of AGM
24th Apr 202011:44 amRNSHolding(s) in Company
23rd Apr 20202:08 pmRNSDirector/PDMR Shareholding
22nd Apr 20207:00 amRNSHolding(s) in Company
20th Apr 20201:58 pmRNSDirector/PDMR Shareholding
16th Apr 20202:57 pmRNSDirector/PDMR Shareholding
7th Apr 20203:45 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.